In this study, we found that ATAD2 expression was significantly associated with lymph node metastasis and advanced clinical stage, and revealed the prognostic role of ATAD2 in a relatively large cohort of ESCC patients. Here, ATAD2 is linked to esophageal squamous cell carcinoma.